Detalles de la búsqueda
1.
Emicizumab does not interfere with the activated clotting time.
Haemophilia
; 28(2): 362-366, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35060654
2.
Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Br J Haematol
; 192(5): 909-921, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33528045
3.
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Crit Care Med
; 49(11): e1151-e1156, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34049308
4.
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
Eur J Haematol
; 105(6): 675-681, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668090
5.
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Eur J Haematol
; 105(2): 103-115, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277501
6.
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.
Haematologica
; 104(12): 2493-2500, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819911
7.
Emicizumab and asparaginase, A first experience to share.
Haemophilia
; 30(2): 561-563, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240017
8.
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.
Haemophilia
; 30(2): 554-557, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146237
9.
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).
Haemophilia
; 25(5): 731-737, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294904
10.
Interferences by factor VIII and lupus anticoagulant in the modified one-stage assay for emicizumab.
Haemophilia
; 29(6): 1661-1664, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751318
11.
Assessing bleeding risk in 18 children with Osteogenesis imperfecta.
Br J Haematol
; 192(4): 785-788, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475155
12.
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.
Haematologica
; 106(8): 2287-2290, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011136
13.
Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy.
Haemophilia
; 27(4): e581-e584, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34004050
14.
Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome.
Acta Derm Venereol
; 96(1): 77-81, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26084625
15.
Ability of hemostatic assessment to detect bleeding disorders and to predict abnormal surgical blood loss in children: a systematic review and meta-analysis.
Paediatr Anaesth
; 25(12): 1216-26, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467201
16.
Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.
Blood
; 119(3): 861-7, 2012 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22130800
17.
Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).
Haemophilia
; 25(5): e327-e330, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294887
18.
A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation.
Haematologica
; 103(12): e613-e617, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115659
19.
Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study.
Thromb Res
; 232: 93-103, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37976734
20.
Heparin-induced thrombocytopenia in newborns: experience at a pediatric hospital and a literature review.
Res Pract Thromb Haemost
; 7(7): 102214, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38077818